Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gidal

Showing results (91-100 of 274) with videos related to

Pageof 28
Sort By:
Epilepsia Open|March 18, 2026
Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approachJ Helen Cross, Rima Nabbout, Barry Gidal, et al.
The Annals of Pharmacotherapy|May 1, 1996
Changes in interleukin-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokineticsB E Gidal, W G Reiss, J S Liao, et al.
Therapeutic Drug Monitoring|June 1, 1995
Optimized method for determination of gabapentin in serum by high-performance liquid chromatographyG L Lensmeyer, T Kempf, B E Gidal, et al.
The Annals of Pharmacotherapy|October 1, 1995
Weight gain and gabapentin therapyB E Gidal, M M Maly, R E Nemire, et al.
Epilepsy Research|December 4, 2003
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trialsBarry E Gidal, Raj D Sheth, Leslie Magnus, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|June 29, 2022
Impact of Clinical Pharmacists on Access to Care in an Epilepsy ClinicMaralena Taube, Robert Kotloski, Ariela Karasov, et al.
Neurology. Clinical Practice|January 3, 2024
Zonisamide: A Comprehensive, Updated Review for the ClinicianBarry E Gidal, Trevor Resnick, Michael C Smith, et al.
Epilepsy & Behavior : E&B|May 10, 2021
Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for cliniciansBarry E Gidal, Jim Ferry, Larisa Reyderman, et al.
Epilepsy Research|June 22, 2002
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoinGail D Anderson, Barry E Gidal, John A Messenheimer, et al.
Epilepsy & Behavior : E&B|January 8, 2022
Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitionersOwen S Miller, Edmund J Elder, Karen J Jones, et al.
Pageof 28

Showing results (91-100 of 274) with videos related to

Sort By:
Pageof 28
Epilepsia Open|March 18, 2026
Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approachJ Helen Cross, Rima Nabbout, Barry Gidal, et al.
The Annals of Pharmacotherapy|May 1, 1996
Changes in interleukin-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokineticsB E Gidal, W G Reiss, J S Liao, et al.
Therapeutic Drug Monitoring|June 1, 1995
Optimized method for determination of gabapentin in serum by high-performance liquid chromatographyG L Lensmeyer, T Kempf, B E Gidal, et al.
The Annals of Pharmacotherapy|October 1, 1995
Weight gain and gabapentin therapyB E Gidal, M M Maly, R E Nemire, et al.
Epilepsy Research|December 4, 2003
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trialsBarry E Gidal, Raj D Sheth, Leslie Magnus, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|June 29, 2022
Impact of Clinical Pharmacists on Access to Care in an Epilepsy ClinicMaralena Taube, Robert Kotloski, Ariela Karasov, et al.
Neurology. Clinical Practice|January 3, 2024
Zonisamide: A Comprehensive, Updated Review for the ClinicianBarry E Gidal, Trevor Resnick, Michael C Smith, et al.
Epilepsy & Behavior : E&B|May 10, 2021
Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for cliniciansBarry E Gidal, Jim Ferry, Larisa Reyderman, et al.
Epilepsy Research|June 22, 2002
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoinGail D Anderson, Barry E Gidal, John A Messenheimer, et al.
Epilepsy & Behavior : E&B|January 8, 2022
Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitionersOwen S Miller, Edmund J Elder, Karen J Jones, et al.
Pageof 28